H.R. 3680, Co-Prescribing to Reduce Overdoses Act, as amended

H.R. 3680

Co-Prescribing to Reduce Overdoses Act, as amended

Sponsor
Rep. John P. Sarbanes

Date
May 11, 2016 (114th Congress, 2nd Session)

Staff Contact
Communications

Floor Situation

On Wednesday, May 11, 2016, the House will consider H.R. 3680, the Co-Prescribing to Reduce Overdoses Act, as amended, under suspension of the rules. H.R. 3680 was introduced on October 10, 2015 by Rep. John Sarbanes (D-MD), and was referred to the Committee on Energy and Commerce, which ordered the bill reported, as amended, by a voice vote, on April 28, 2016.

Bill Summary

H.R. 3680 would establish a grant program to encourage the prescribing of opioid overdose reversal drugs such as naloxone. The grant program would provide resources for health care providers and pharmacists on the prescribing of opioid reversal drugs, and would develop mechanisms to track patients participating in the grant program. Additionally, the grant program would provide for a limited financial coverage of costs associated with opioid reversal drugs and conduct community outreach designed to raise awareness of co-prescribing practices.

Any eligible grant recipient would be required to report to the Secretary of Health and Human Services information on appropriate outcome measures specified by the Secretary.

Finally, a grant made under this program may not exceed $200,000 per grant.

Background

The United States is experiencing an epidemic of drug overdose deaths. Since 2000, the rate of deaths from drug overdoses has increased 137 percent, including a 200 percent increase in the rate of overdose deaths involving opioids (opioid pain relievers and heroin). During 2014, a total of 47,055 drug overdose deaths occurred in the United States, with more than 28,000 deaths involving some type of opioid, including heroin.[1]

Naloxone is a medication used to treat the effects of opioids, particularly those of an overdose. Naloxone can be prescribed to patients or the family members of individuals who are at risk of overdosing on opioids.

According to a press release issued by the bill sponsor, “the increase in opioid overdoses is a national crisis that cuts too many lives short and tears too many families apart. The bipartisan solutions we’ve advanced today, like the Co-Prescribing to Reduce Overdoses Act, will help expand access to lifesaving treatment for thousands of Americans.”[2]

—————-
[1] See CDC: Increases in Drug and Opioid Overdose Deaths – United States, 2000-2014
[2] https://democrats-energycommerce.house.gov/newsroom/press-releases/committee-advances-12-bills-to-address-opioid-abuse-epidemic

Cost

A Congressional Budget Office estimate is currently unavailable. However, H.R. 3680 authorizes $5,000,000 for each of the fiscal years 2017 through 2021. The legislation is cut-go compliant.

Additional Information

For questions or further information please contact Jason Grassie with the House Republican Policy Committee by email or at 3-1555.